Dienogest/ethinylestradiol extended release - Exeltis
Alternative Names: Ethinyl estradiol/dienogest; LPRI-421; LPRI-424Latest Information Update: 01 Dec 2023
Price :
$50 *
At a glance
- Originator Exeltis
- Developer Chemo Research, S.L.; Exeltis
- Class Alkylated estrogenic steroids; Antiandrogens; Estrenes; Hormonal contraceptives; Norpregnatrienes; Oral contraceptives; Testosterone congeners
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists; Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Hirsutism; Pregnancy
Most Recent Events
- 08 Sep 2023 Insud Pharma completes phase III trial in Pregnancy (Prevention, In volunteers) in USA (PO) (NCT03945513)
- 27 Sep 2021 Phase-III clinical trials in Hirsutism (In adolescents, In adults) in Spain, Czech Republic, Slovakia (PO) (EudraCT2021-002178-17)
- 02 Jul 2021 Phase-III clinical trials in Hirsutism (In adolescents, In adults) in Poland (PO) (EudraCT2021-002178-17)